The interplay between angiogenic signaling, including VEGF and HGF, and PD-L1 in tumor creates a synergistic axis where impaired vascular integrity and increased pericyte coverage correlate with increased PD-L1 levels, promoting immune escape [112]. The gene discussed is HGF; the disease is neoplasm.